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DRUG SENSITIVITY TESTS FOR TUBERCLE BACILLI 
S.   SUBBAMMAL 
(From Tuberculosis Chemotherapy Centre, Madras} 
You have heared from Dr. Narasirahan about 
the various methods of determining the sensiti-
vity of tubercle bacilli to antituberculosis drugs. 
You have also seen from Dr. Kulkarni's pre-
sentation that the agreement between duplicate 
tests on the same culture or between tests on 
two cultures obtained from a patient at almost 
the same time is only 80%—90% for streptomy-
cin or isoniazid, and even less for PAS or thio-
cetazone, if one considers only patients with 
drug-resistance. Such variation also occurs in 
drug-sensitive cultures, as can be seen from the 
results of sensitivity tests on the standard strain, 
H37Rv, which is usually employed as a control. 
The MIC of this strain in the standard test 
varies from 2—32 ug/ml streptomycin, the mode 
being 8 ug/ml. If such a 4-fold difference in 
the MIC can occur with one strain set up with 
the same method by the same technician, one 
may expect similar variation in the MIC of test 
strains obtained from patients. The interpre-
tation of the result of a single test on a patient's 
strain therefore becomes difficult. For the 
interpretation of such a result to be meaningful, 
one must obtain precise definitions of drug 
resistance for each method, taking into consi-
deration variations resulting from the errors of 
the test, 
Mitchison in 1962 defined resistance as "a 
decrease in sensitivity of sufficient degree to be 
reasonably certain that the strain concerned is 
different from a sample of wild strains of 
human type that have never come into contact 
with the drugs". Sensitivity tests are designed 
with the object of detecting such a decrease in 
sensitivity. The most efficient criterion of resis-
tance may be slightly different from one labora-
tory to another. Further, measures of sensitivity 
are expressed on different scales by the 3 methods 
of sensitivity tests. Comparison of such methods 
can be valid only if objective methods of cali-
bration of sensitivity tests are employed. 
In the past, a common approach was to test 
a sample of strains isolated before the start of 
treatment with a drug, and therefore presumed 
to be sensitive strains. Strains were considered 
resistant if they were slightly more resistant 
$han the great majority of sensitive strains. 
This procedure has the inherent defect that 
arbitrary criteria are to be employed to remove 
from the population of sensitive strains those 
which are considered to have natural or primary 
resistance. 
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A second approach is to consider the results 
of the treatment of patients who have varying 
degree of sensitivity at the start of treatment 
and to try to determine the level of sensitivity 
at which there is a change in the therapeutic 
response. This, however, is not feasible since 
it is not the practice to treat a tuberculosis 
patient with one drug alone. 
The best approach is to compare the sensi-
tivity of a sample of strains from untreated 
patients (a predominantly sensitive sample) 
with a sample of strains from patients who have 
been treated with the drug for at least a few 
months (a predominantly resistant sample). The 
criterion of resistance that discriminates bet-
ween the two samples with the greatest 
efficiency can then be chosen. Even with this 
method, some misclassification of sensitive 
strains as resistant, and vice versa, can occur. 
To avoid misclassification of sensitive strains 
as resistant, it is preferable to choose a sensi-
tive strain, although it may occasionally fail to 
detect strains with border-line degrees of resis-
tance. 
We have employed this approach in our 
laboratory for the purpose of comparison of 
various methods of testing mycobacterial drug-
sensitivity. 
An example of sensitivity test of dihydro-
streptomycin is shown in Table I. The test was 
set up by using a standard suspension St and 4 
successive 10-fold dilutions, S2, S3, S4, and S5. 
The readings have been taken at 40 days, and 
the growth on dihydrostreptomycin slopes has 
been expressed as a proportion of the growth 
on the drug-free slopes. This design also per-
mits interpretation of the results as MICs, if 
read horizontally. This basic design has been 
used in our laboratory for all comparative 
studies with streptomycin, isoniazid, ethambu-
tol, pyrazinamide and PAS. 
Dihydrostreptomycin sensitivity tests were 
performed on 960 presumably sensitive 
(PR) strains obtained during chemotherapy 
with regimens containing streptomycin. Table 
2 presents the sensitivity of these cultures as 
assessed by the proportion resistant to dihydro-
streptomycin 4 ug/ml. Comparing the sensi-
tivity of the PS and the PR populations at the 
various levels of resistance to dihydrostrepto-
mycin 4 ug/ml, the highest discrimination (last 
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TABLE 1  
Dihydrostreptomycin proportion sensitivity lest—example 
 
  Dihydrostrep. Cone. (ug/ml) 
Suspension  Drug- free  2                 4                 1                 16  
Standard   (Si)  3 +  (50,000)  2+-             2+           11                 0  
1 in 10   (S1)  3-1-  (5,000)  2+             26              2  
1 in 103 (S3)  2+        2+  (500)  32                4               0  
1 in 103 (S4)  46         54  (50)  4                 1               0  
1 in 10* (S5)  8           8    
Proportion resistant  6.4%           0.52%       0.02%  
TABLE 2  
Proportion resistant to 4 ug\m\ Dihydrosireplomycin 
 
Proportion resistant  PS 
(%)  
PR                          Difference 
(%)  
1% or more  16  81                                  65  
5% or more  10  72                                  62  
10% or more  9  69                                  60  
25% or more  7  61                                  54  
50% or more  5  47                                  42  
No. of cultures  960  734  
column) occurs with a definition of 1 % or 
more; such a definition, however, would mis-
classify 16% of PS cultures as resistant, and is 
therefore unacceptable. A definition of 25% 
or more would label only 7% of such strains 
as resistant, and also provide a high degree of 
discrimination between the two populations, 
and is therefore acceptable. This approach 
was utilised to define resistance by other 
methods of testing. 
Definitions of resistance were similarly 
derived by similar process for MIC and RR 
for streptomycin and MIC proportions on 
dihydrostreptomycin (Table 3). It will be noted 
that all measures classified less than 10% of the 
PS population as resistant. Definitions based 
on MIC or RR of streptomycin, or MIC of 
dihydrostreptomycin were as satisfactory as the 
best proportion, namely >1% on 8 ug/ml. 
The patients whose pretreatment cultures 
were included in this study were all prescribed 
regimens of intermittent chemotherapy con-
taining streptomycin as one of the drugs. The 
response to treatment for a period of 12 months 
could be assessed in about 840 patients. In 
these patients it was possible to study the prog-
nostic significance of pretreatment resistance to 
streptomycin & dihydrostreptomycin, as defined 
by the discrimination approach (Table 4). 
Considering a definition of MIC >32 ug/ml. 
52% of patients having resistant bacilli had an 
unfavourable response, compared with 16% of 
the sensitive patients, a highly significant diffe-
rence (P<0.001). Differences in the response 
of the sensitive and the resistant populations 
are highly significant for each of the remaining 
definitions. Thus, the definitions obtained by 
employing the discrimination approach are 
clinically meaningful. 
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TABLE 3  
Definitions of resistance to streptomycin 
 
%  classified 
as resistant  
Definition  
PS  PR (6-12)  
Difference  
Strep      
MIC       >32 ug/ml  6 69  63  
RR         >4 7 71  64  
Dihydrostrep      
MIC           > 32 ug/ml  5 65  60  
>50%on  2 ug/ml  10 61  51  
>25% on  4 ug/ml  7 61  54  
>l%on  1 ug/ml  8 70  62  
No. of cultures  960 739  
TABLE 4  
Prognostic significance of resistance to streptomycin 
 
Patients with an unfavourable response 
% 
Definition 
Sensitive  Resistant  
MIC DS> 32 ug/ml  16  52  
MIC Strep. > 32 ug/ml  16  44  
RR Strep>4  16  42  
>50% on DS 2 ug/ml  16  36  
> 5% on DS 4 ug/ml  16  38  
>l%on DS 8 ug/ml  16  46  
No of patients  778-812  29-72  
The cultures tested for streptomycin sensiti-
vity were also tested for their susceptibility to 
isoniazid. The definitions of isoniazid resis-
tance which discriminate most efficiently bet-
ween the PS and the PR populations are 
presented in Table 5. All the measures, includ-
ing the MIC method, appear to be of equal 
efficiency in detecting acquired resistance. Cor-
relating the pretreatment isoniazid resistance 
with response to treatment, the proportion of 
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patients with unfavourable response among the 
sensitive group was found to be 16%, compared 
to 55-76% among those with resistance, a high-
ly significant difference, providing evidence that 
for isoniazid also, the definitions of resistance 
are clinically meaningful. 
The discrimination approach was also 
applied to pretreatment cultures and for cultu-
res isolated from patients who had been treated 
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TABLE 5                                
Definitions of resistance to isoniazid 
 
 %classified as 
resistant Definition 
PS PR  
Difference 
MIC   > 1 ug/ml  5 64  59  
> 5% on 0.1 ug/ml  6 66  60  
>0.5% on 0.2 ug/ml  6 65  59  
> 0.1% on 0.2 ug/ml  6 63  57  
No. of cultures  959 740   
TABLE 6  
Definitions of resistance to ethambutol 
 
% classified as 
resistant  
Definition  
PS PR (4-12)  
Difference  
S1-20 col. MIC>8 ug/ml  1 40  39  
S2-l0col. MIC >8 ug/ml  1 42  41  
S3-10col. MIC >2.8 ug/ml  1 42  41  
>25% OQ 1.4 ug/ml  0 27  37  
>5% on 2.0 ug/ml  0 43  43  
>0.5% on 2,8 ug/ml  1 43  42  
No. of cultures  81 87   
with ethambutol for various periods. The rela-
tive efficiencies of the various proportion 
measures of resistance are shown in Table 6. 
Definitions of proportions on 2 ug/ml or on 
2,8 ug/ml are equally efficient. The MIC defini-
tions of resistance are also presented in Table 6. 
It may be noted that a definition of MIC 8 
ug/ml or more is as efficient as the proportion 
definitions shown earlier. 
Information on the clinical significance of 
these measures of resistance is not as yet avail-
able. This information will be available when 
all the patients complete their scheduled course 
of chemotherapy. 
Earlier studies from this Centre had shown 
that sensitivity tests for PAS, employing an 
MIC or an RR type of test, was unsatisfactory 
for Indian cultures of tubercle bacilli, largely 
because of a high percentage of pretreatment 
cultures from Indian patients having low sus-
ceptibility to PAS. It was felt that the propor-
tion test may prove more efficient. A comparative 
study was therefore undertaken on pretreatment 
cultures (PS) and on cultures isolated from 
patients while receiving treatment with PAS 
plus isoniazid daily or twice a week. 
Table 7 presents the definitions of resistance 
to PAS. The best definition is proportion on 
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TABLE 7     
 Definitions of resistanee to PAS 
 
% classified as 
resistant  
Definition  
PS PR (7-12)  
Difference  
MIC >2 ug/ml  6 28  22  
RR>4  5  31  26  
> 10% on 0.25 ug/ml  7 26  19  
>5%on0.5  ug/ml  5  28  23  
>l%onl ug/ml  7 39  32  
No. of cultures  235 218   
TABLE 8               
Definitions of resistance to pyrazinamide 
 
%  classified as resistant  
Definition  
PS  PR (4-12)*  
Difference  
MIC@> 100 ug/ml  8  48  40  
> 20% on 25 ug/ml  5  46  41  
>5%on 50 ug/ml  5  48  43  
>l%on 100 ug/ml  5  50  45  
No. of cultures  268  101   
•Obtained from patients during the 4th and the 12th months of chemotherapy with daily regimens which 
included pyrazinamide                                                                                                                                   
@Employing a 1 in 10 dilution and a 10-colony end-point 
1 ug/ml, with a difference of 32%. We have 
not been able to study the clinical significanse, 
as any deficiency of this drug is compensated 
to a large extent by the highly active companion 
drug, isoniazid. 
Table 8 presents definition of pyrazinamide 
resistance, derived by application of the dis-
crimination approach. The best definition is 
proportion on 100 ug/ml; however, the MIC 
definition is almost as efficient, and has the 
great merit of simplicity. 
So far, I have presented data on indirect 
sensitivity tests. As Dr. Narasimhan said 
earlier, such tests take at least 2 months for 
results to be available. Direct tests provide 
information on drug-sensitivity in 2-4 weeks 
time, and would therefore be useful in the 
management of cases. I shall briefly present 
data on a direct sensitivity test developed by my 
colleague, Sara Mathew. 
In this test, 6 swabs are prepared from each 
sputum, and transferred to test-tubes half-filled 
with 1% sterile solution of cetrimide. After 
60 minutes, the swabs are drained of excess 
fluid, and are smeared on the entire surface of 
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TABLE 9 
Direct sensitivity results by swab method             
Isoniazid sensitivity results by indirect and swab method 
 
Swab test read at :  
Indirect 
Test  
Swab 
Test  3 weeks  4 weeks  8 weeks  
Sensitive 
Resistant  
Sensitive 
Resistant  
       57 
                         94% 
     121  
55 
                 93% 
130 
   61 
                     95% 
  134 
Resistant  Sensitive  9                5%  8                4%  6            3%  
Sensitive  Resistant  2               1%  5                3%  5            2%  
Total specimens  189  198  206  
TABLE 10 
Direct Sensitivity results by swab method Streptomycin 
sensitivity test by indirect and swab methods 
 
Swab test read at :  Indirect 
Test  
 
Swab 
Test  
3 weeks  4 weeks  8 weeks  
Sensitive 
Resistant 
Resistant 
Sensitive  
Sensitive 
Resistant 
 
Sensitive 
Resistant  
70              
                  82% 
83  
 
30            16% 
4               2%  
70                       
                           88% 
104  
17               9%       
6               3%  
72 
            90% 
113 
11 
10 
Total specimens  198  197  206  
2 drug-free L-J slopes, and 2 slopes each con-
taining 16 ug/ml streptomycin on 0.2 ug/ml of 
isoniazid. The slopes are then incubated up 
to 8 weeks, and read each week. Any 
growth on 16 ug/ml or growth on 0.2 ug/ml is 
taken as indication of resistance. 
The results of direct sentitivity tests on 206 
sputum specimens were compared with those 
of indirect sensitivity tests on cultures 
obtained from the 206 specimens. Table 9 
shows the extent of agreement between the 
results of the direct and the indirect 
sensitivity tests for isoniazid. The 
agreement is of the order of 93% at 4 
weeks, and 95% at 8 weeks. The 
corresponding figures for streptomycin 
were 88% at 4 weeks and 90% at 8 weeks 
(Table 10). 
Thus, the swabs sensitivity test gave results 
which were closely similar to those of the 
indirect sensitivity tests for streptomycin 
and isoniazid. The test is simple, easy to 
set up and economical. The test can 
therefore be set up in any laboratory which 
has facilities for culturing sputum. Even so, 
a period of 4-8 weeks must elapse before 
the test result is available. This period 
could perhaps be curtailed by the 
application of slide culture techniques in 
sensitivity test procedures. 
I am grateful to the Indian Council of 
Medical Research for permitting me to 
present this paper at the 27th Tuberculosis 
and Chest Diseases Workers Conference. 
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